cbdMD, Inc.
Financial highlights
| Metric | FY 09/30/25 | FY 09/30/24 | FY 06/30/24 | FY 03/31/24 | FY 12/31/23 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $19.2M | $19.9M | — | — | — |
| Cost of revenue | $7.2M | $7.5M | — | — | — |
| Gross profit | $12.0M | $12.0M | — | — | — |
| Operating income | -$2.2M | -$3.3M | — | — | — |
| Pretax income | -$2.0M | -$3.7M | — | — | — |
| Income tax expense | $0 | $0 | — | — | — |
| Net income | -$2.0M | -$3.7M | — | — | — |
| Balance Sheet | |||||
| Cash and equivalents | $2.3M | $2.5M | — | — | — |
| Current assets | $6.6M | $6.4M | — | — | — |
| Total assets | $10.4M | $10.6M | — | — | — |
| Current liabilities | $3.2M | $8.6M | — | — | — |
| Total liabilities | $3.2M | $8.6M | — | — | — |
| Stockholders' equity | $7.2M | $2.0M | $3.0M | $3.1M | $7.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$1.5M | -$352,792 | — | — | — |
| Depreciation and amortization | $361,063 | $452,326 | — | — | — |
| Capital expenditure | $184,172 | $190,015 | — | — | — |
| Free cash flow | -$1.6M | -$542,807 | — | — | — |
Shares outstanding 10.5M · Free float 89.4%
Annual filing data through FY ended September 30, 2025; float as of July 14, 2026.